AMBER THERAPEUTICS LIMITED

Active Didcot

Research and experimental development on biotechnology

3 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology
A

AMBER THERAPEUTICS LIMITED

Research and experimental development on biotechnology

Founded 14 Jun 1993 Active Didcot, England 3 employees website.com
Life sciences and medical technology Research and experimental development on biotechnology

Previous Company Names

FINETECH MEDICAL LIMITED 14 Jun 1993 — 11 Jul 2024
Accounts Submitted 5 Sept 2025 Next due 30 Sept 2026 3 months remaining
Confirmation
Net assets £-327K £490K 2023 year on year
Total assets £227K £106K 2023 year on year
Total Liabilities £554K £383K 2023 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Unit 1 Tech Foundry 2 Curie Avenue Didcot OX11 0QQ England

Website

www.example.com

Full company profile for AMBER THERAPEUTICS LIMITED (02826839), an active life sciences and medical technology company based in Didcot, England. Incorporated 14 Jun 1993. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type total-exemption-full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2015–2023)

Cash in Bank

£59.36k

Increased by £2.16k (+4%)

Net Assets

-£327.01k

Decreased by £489.52k (-301%)

Total Liabilities

£554.11k

Increased by £383.18k (+224%)

Turnover

N/A

Employees

3

Decreased by 3 (-50%)

Debt Ratio

244%

Increased by 193 (+378%)

Financial History

Revenue, profit, EBITDA and key financial figures

2023
31 Dec Year End
2022
30 Jun Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 2
Grants 1

Investors (6)

Investor NameInvestor SinceParticipating Rounds
Investor 1Jan 2023Series A, Seed
Investor 6Jan 2023Series A, Seed
Investor 2Jun 2024Series A

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 28,765,721 Shares £28.77m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
30 Oct 202528,765,721£28.77m£1

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (2)

Amber Therapeutics Holdings Limited
100.0%
100
Bioinduction Medical Limited
0.0%
0

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased
Notified 22 Jul 2024
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Bioinduction Medical Ltd

Ceased 22 Jul 2024

Ceased

Group Structure

Group Structure

AMBER THERAPEUTICS LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
3 Nov 2025Change Of ConstitutionStatement Of Companys Objects
3 Nov 2025IncorporationMemorandum Articles
3 Nov 2025ResolutionResolutions
31 Oct 2025InsolvencySolvency Statement dated 30/10/25
31 Oct 2025ResolutionResolutions
3 Nov 2025 Change Of Constitution

Statement Of Companys Objects

3 Nov 2025 Incorporation

Memorandum Articles

3 Nov 2025 Resolution

Resolutions

31 Oct 2025 Insolvency

Solvency Statement dated 30/10/25

31 Oct 2025 Resolution

Resolutions

Recent Activity

Latest Activity

Statement Of Companys Objects

7 months ago on 3 Nov 2025

Memorandum Articles

7 months ago on 3 Nov 2025

Resolutions

7 months ago on 3 Nov 2025

Solvency Statement dated 30/10/25

7 months ago on 31 Oct 2025

Resolutions

7 months ago on 31 Oct 2025